109 Results for "

Cleavable,linker

" in MedChemExpress (MCE) Product Catalog:
Products (109)

109 Results for "Cleavable,linker" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-20336
CAS No.: 159857-81-5
Synonyms: Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate
Target:  

ADC Linkers

Research Areas:  

Others Inflammation/Immunology Cancer

Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-126681
CAS No.: 2259318-46-0
Purity:  98.01%
Synonyms: NHS-VC-PAB-MMAE
Research Areas:  

Cancer

SC-VC-PAB-MMAE (NHS-VC-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker SC-VC-PAB .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99542
CAS No.: 2254086-60-5
Synonyms: SAR-408701; HuMAb2-3-SPDB-DM4
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99101
CAS No.: 2490556-50-6
Synonyms: AEX-4089; MGC026 antibody

Target:  

ADC Antibodies

Research Areas:  

Cancer

Vobramitamab is a humanized B7-H3 monoclonal antibody (mAb). Vobramitamab conjugated with prodrug seco-DUBA (HY-132180A) via a cleavable linker, to form antibody-drug conjugate (ADC), the MGC018. MGC018 displays potent antitumor activity in preclinical tumor models of breast, ovarian, and lung cancer, as well as melanoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126350
CAS No.: 1036969-20-6
Purity:  99.14%
Research Areas:  

Cancer

CL2-SN-38 is a cleavable linker-based agent-Linker conjugate, it can conjugate with the anti-Trop-2-humanized antibody hRS7. CL2-SN-38 can be used for the reasearch of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W190943
CAS No.: 1869126-64-6
Research Areas:  

Cancer

Azido-PEG4-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker Azido-PEG4-Val-Cit-PAB-OH . Azido-PEG4-Val-Cit-PAB-MMAE is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
Cat. No.: HY-41189
CAS No.: 863971-53-3
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers .
loading...
    loading...
Cat. No.: HY-153180
CAS No.: 2851058-71-2
Purity:  98.99%
Research Areas:  

Cancer

PB038 is a Drug-liker containing a PEG unit and a cleavable linker attached to Exatecan .
loading...
    loading...
Cat. No.: HY-44235
CAS No.: 1599440-15-9
Target:  

ADC Linkers

Research Areas:  

Cancer

MC-Gly-Gly-Phe is a cleavable linker used for antibody-drug conjugates (ADC).
loading...
    loading...
Cat. No.: HY-101162
CAS No.: 1342820-51-2
Purity:  96.17%
Research Areas:  

Cancer

SGD-1910 is a agent-linker conjugate for ADC by using the antitumor antibiotic, pyrrolobenzodiazepine (PBD, a cytotoxic DNA crosslinking), linked via the cleavable linker MC-Val-Ala .
loading...
    loading...
Cat. No.: HY-115524
CAS No.: 1384870-47-6
Purity:  ≥97.0%
Target:  

ADC Linkers

Research Areas:  

Cancer

DBCO-NHS ester 2 is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 2 is a derivative of Dibenzylcyclooctyne (DBCO) used in copper-free click chemistry[1]. DBCO-NHS ester 2 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-153360
CAS No.: 2873460-70-7
Purity:  98.99%
Research Areas:  

Cancer

MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
loading...
    loading...
Cat. No.: HY-P1449
CAS No.: 187794-49-6
Target:  

ADC Linkers

Research Areas:  

Cancer

Boc-Gly-Gly-Phe-Gly-OH, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate (ADC).
loading...
    loading...
Cat. No.: HY-W011561
CAS No.: 142356-33-0
Target:  

ADC Linkers

Research Areas:  

Cancer

Boc-NH-C6-Br is a non-cleavable linker used for antibody-drug conjugates (ADC) .
loading...
    loading...
Cat. No.: HY-44980
CAS No.: 1599440-06-8
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Gly-NH-CH2-acetyloxy is a cleavable linker that can be used to synthesize antiboy-drug Conjugates (ADCs).
loading...
    loading...
Cat. No.: HY-173639
Research Areas:  

Cancer

AZD0516 is an antibody-drug conjugate (ADC) targeting STEAP2. It is formed by conjugating an anti-STEAP2 monoclonal antibody (mAb) via interchain cysteines to a maleimide-reactive, β-glucuronidase-cleavable linker (HY-173635) and the topoisomerase 1 inhibitor Exatecan (HY-13631). AZD0516 is applicable to the research of metastatic castration-resistant prostate cancer .
loading...
    loading...
Cat. No.: HY-126498
CAS No.: 874302-76-8
Purity:  99.88%
Target:  

ADC Linkers

Research Areas:  

Cancer

PDEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate (ADC).
loading...
    loading...
Cat. No.: HY-W071967
CAS No.: 1343407-91-9
Target:  

ADC Linkers

Research Areas:  

Cancer

Alloc-Val-Ala-PAB is a peptide cleavable linker used in the synthesis of antibody-drug conjugates (ADCs). The Val-Ala will specifically be cleaved by Cathepsin B. The Alloc group is stable to treatment with piperidine and TFA, but can be easily removed under mild conditions by palladium catalyzed allyl transfer.
loading...
    loading...
Cat. No.: HY-132257
CAS No.: 1613313-09-9
Synonyms: SC-002
Research Areas:  

Cancer

Rovalpituzumab tesirine (SC-002) is an antibody-drug conjugate (ADC) with anticancer effects. Rovalpituzumab tesirine contains a DLL3-targeting antibody Rovalpituzumab (HY-P99043) tethered to a cytotoxic agent pyrrolobenzodiazepine by means of a protease-cleavable linker. Rovalpituzumab tesirine can be used for the stduy of small cell lung cancer (SCLC) .
loading...
    loading...
Cat. No.: HY-P99683
CAS No.: 1629760-29-7
Synonyms: SGN-LIV1A
Research Areas:  

Cancer

Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC50: 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer .
loading...
    loading...